Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 14, 2025

SELL
$713.71 - $898.95 $713 - $898
-1 Reduced 0.3%
333 $260 Million
Q1 2025

May 01, 2025

BUY
$725.72 - $929.72 $23,948 - $30,680
33 Added 10.96%
334 $276 Million
Q4 2024

Feb 05, 2025

BUY
$727.2 - $932.06 $218,887 - $280,550
301 New
301 $232 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track A&I Financial Services, LLC Portfolio

Follow A&I Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of A&I Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on A&I Financial Services, LLC with notifications on news.